Stock Screener App

Gratuito -

Installare

38.85

1.60% 0.61

Immunovant Inc (IMVT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IMVT Giù? Forum Previsione

Immunovant Inc Azioni (IMVT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	13.21% 114.36	131.76	127.22	115.74	94.28
Income/Loss From Continuing Operations Before Tax	13.36% -109.08	-125.91	-119.70	-109.04	-87.07
Income Tax Expense/Benefit	161.28% 1.552	0.594	0.913	0.078	0.077
Income/Loss From Continuing Operations After Tax	12.54% -110.64	-126.50	-120.61	-109.12	-87.15
Net Income/Loss	12.54% -110.64	-126.50	-120.61	-109.12	-87.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.53% 181.51	173.64	170.87	146.47	146.09
Diluted Average Shares	4.53% 181.51	173.64	170.87	146.47	146.09
Basic Earnings Per Share	16.44% -0.61	-0.73	-0.71	-0.74	-0.60
Diluted Earnings Per Share	16.44% -0.61	-0.73	-0.71	-0.74	-0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

BNTX

$91.22

1.36%

ROIV

$34.07

0.15%

RPRX

$56.23

2.82%

MRNA

$67.27

12.59%

ONC

$279.89

1.65%

RVMD

$182.08

2.19%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters